Neogen Corporation (Neogen), a in vitro diagnostics company, has appointed Jennifer Rice as its senior scientific officer. In this newly created position, Rice will have responsibility for the overall direction of Neogen’s research activities. Rice joins Neogen after serving in a position of Animal Health Global Product Development with Dow AgoSciences (Dow) in Indianapolis.
Prior to the Dow appointment, she served as director of Research and Development for Biocor Animal Health (Biocor) where she was responsible for all aspects of design and development for animal vaccines and diagnostic tests. Her team was responsible for the licensure of several bovine combination vaccines.
Prior to Biocor, she spent five years with Merial in Athens, Ga., in various capacities including director of US Biological Discovery And Development. While there, her team developed and obtained a USDA approval for several vaccines for bovine, canine, and feline species. Earlier in her career, she spent time in research and research management at both Fort Dodge Animal Health and American Cyanamid. During her career, she has been closely involved with USDA approvals of several products and is listed as an inventor in numerous patents and patent applications.
Rice has also been active in several industry related groups including serving as the chairman of the Veterinary Services Committee of the Animal Health Institute.
“Dr. Rice brings outstanding experience and educational background to this new position,” said James Herbert, Neogen’s chief executive officer. “She has a good understanding of opportunities for future product development and the experience of managing global programs involving large groups of scientists and multiple product activities.”